Follow Procter & Gamble to never miss an important update.
Italy's antitrust regulator closed its investigation into the company's advertising claims for a hair removal device. The probe ended after the company committed to changing its marketing to address the regulator's concerns. This is a routine regulatory matter that has been resolved without a fine, and it does not change the outlook for the business.
Source: Reuters
Argus Research lowered its rating on the stock from Buy to Hold. This change reflects a more cautious view on the company's ability to grow sales in a market where shoppers are becoming more sensitive to price increases.
While the company owns essential brands like Tide and Gillette, it has relied heavily on raising prices to drive growth lately. Analysts are now watching to see if those higher prices will eventually push customers toward cheaper store brands, which would make it harder for the company to maintain its profit levels.
Procter & Gamble disclosed a change to its executive team or board of directors in a recent filing with the SEC, the government agency that oversees public companies. These filings are required whenever there is a shift in the small group of people running the business.
For a company as large as P&G, which manages dozens of household brands like Tide and Gillette, leadership transitions are a routine part of long-term planning. While the company did not immediately name a specific successor or reason for the change in this summary, these moves are closely watched to see if they signal a shift in how the company plans to grow or manage its costs.
Source: 8-K filing
The company reached a deal to buy Thorne, a firm that sells science-backed vitamins and health supplements, for 3.8 billion dollars in cash. This is a clear move to grow its presence in the wellness market, adding a premium brand to a health portfolio that already includes names like Vicks and Pepto-Bismol.
For a company that relies on household staples, this acquisition provides a new way to reach shoppers who are increasingly focused on longevity and preventative health. While the price is significant, it fits the company's strategy of owning top-tier brands in categories where people are willing to pay more for quality.
Source: PRNewsWire
HSBC analysts moved their rating from Buy to Hold and set a price target of 149 dollars. The change comes after the company reported that the total amount of products sold did not grow last quarter, as higher prices and economic pressure caused some shoppers to pull back.
This downgrade reflects a more cautious view on how quickly the company can grow in a tough environment. While the business remains highly profitable, analysts are watching closely to see if it can win back shoppers who have switched to cheaper store brands or smaller pack sizes to save money.
Source: HSBC
Management consistently sets a predictable bar and clears it by a few cents. This steady record suggests they have a tight grip on their costs and pricing.
| Expectation | |
|---|---|
| EPS | $1.88 |
| Revenue | $22.72B |
Follow Procter & Gamble to get the latest and most important updates.
Follow PG